Gujarat Kidney And Super Speciality (NSE:GKSL) Long-Term Debt: ₹17.9 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:GKSL Gujarat Kidney And Super Speciality Ltd NSE:GKSL
18 GF Score
Price ₹127.30
! 3 Warning Signs
View Full Analysis

What is Gujarat Kidney And Super Speciality Long-Term Debt?

Gujarat Kidney And Super Speciality NSE:GKSL -0.04% 18 Long-Term Debt is ₹17.9 Mil as of Mar. 2026. GuruFocus rates NSE:GKSL with a GF Score™ of 18/100. The stock has 3 warning signs investors should review.

Gujarat Kidney And Super Speciality's Long-Term Debt for the quarter that ended in Mar. 2026 was ₹17.9 Mil.

Gujarat Kidney And Super Speciality's quarterly Long-Term Debt declined from Jun. 2025 (₹46.7 Mil) to Dec. 2025 (₹0.0 Mil) but then increased from Dec. 2025 (₹0.0 Mil) to Mar. 2026 (₹17.9 Mil).

Gujarat Kidney And Super Speciality's annual Long-Term Debt declined from Mar. 2024 (₹91.0 Mil) to Mar. 2025 (₹47.9 Mil) and declined from Mar. 2025 (₹47.9 Mil) to Mar. 2026 (₹17.9 Mil).

Gujarat Kidney And Super Speciality  (NSE:GKSL) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Gujarat Kidney And Super Speciality Long-Term Debt Related Terms

Gujarat Kidney And Super Speciality Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Gujarat Kidney And Super Speciality's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gujarat Kidney And Super Speciality Long-Term Debt Chart

Gujarat Kidney And Super Speciality Annual Data
Trend Mar23 Mar24 Mar25 Mar26
Long-Term Debt
122.31 91.01 47.94 17.86

Gujarat Kidney And Super Speciality Quarterly Data
Mar23 Mar24 Dec24 Mar25 Jun25 Dec25 Mar26
Long-Term Debt Get a 7-Day Free Trial 0.00 47.94 46.69 0.00 17.86
NSE:GKSL
18GF Score
Gujarat Kidney And Super Speciality Ltd NSE:GKSL
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of ₹17.9 Mil mean?
Gujarat Kidney And Super Speciality (NSE:GKSL) has a Long-Term Debt of ₹17.9 Mil as of Mar. 2026.
Is Gujarat Kidney And Super Speciality's Long-Term Debt too high?
Gujarat Kidney And Super Speciality's current Long-Term Debt is ₹17.9 Mil. Overall, Gujarat Kidney And Super Speciality has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Gujarat Kidney And Super Speciality's Long-Term Debt compare to HCA and THC?
Gujarat Kidney And Super Speciality's Long-Term Debt of ₹17.9 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Healthcare Providers & Services company?
A good Long-Term Debt depends on the Healthcare Providers & Services industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Gujarat Kidney And Super Speciality's current Long-Term Debt is ₹17.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gujarat Kidney And Super Speciality stock overvalued right now?
Gujarat Kidney And Super Speciality (NSE:GKSL) has a current Long-Term Debt of ₹17.9 Mil. The current Long-Term Debt is ₹17.9 Mil. Gujarat Kidney And Super Speciality's overall GF Score™ is 18/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Gujarat Kidney And Super Speciality (NSE:GKSL), the current Long-Term Debt is ₹17.9 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Gujarat Kidney And Super Speciality Business Description

Other Exchanges 544666:India
Address Jetalpur Road, Gokak Mill Compound, Plot No. 1, City Sarve No. 1537/A, Jetalpur Bridge, Anand Nagar, Haripura, Alkapuri, Vadodara, GJ, IND, 390 020
Gujarat Kidney And Super Speciality Ltd is engaged in the business of operating a chain of mid-sized multispeciality hospitals in central Gujarat and providing integrated healthcare services, with a focus on secondary and tertiary care. It offers a range of healthcare services, including General Medicine, General Surgery, Laparoscopic Surgery, Urology, Cardiology, Nephrology, and many more. The company operates in a single segment, namely Medical and Healthcare Services. It generates a substantial portion of revenue from its services to inpatients. Geographically, it operates only in India.
18GF Score

Get the complete analysis for NSE:GKSL

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹127.30
Price